These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32221166)

  • 1. Population Pharmacokinetics of Cefoxitin Administered for Pediatric Cardiac Surgery Prophylaxis.
    Ricci Z; Benegni S; Cies JJ; Marinari E; Haiberger R; Garisto C; Rizza A; Giorni C; Di Chiara L; Arpicco S; Muntoni E; Ferrari F; Milla P
    Pediatr Infect Dis J; 2020 Jul; 39(7):609-614. PubMed ID: 32221166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoxitin Prophylaxis During Pediatric Cardiac Surgery: Retrospective Exploration of Postoperative Trough Levels.
    Ricci Z; Benegni S; Cies JJ; Marinari E; Haiberger R; Garisto C; Cairoli S; Di Chiara L; Goffredo B
    Pediatr Infect Dis J; 2019 May; 38(5):484-489. PubMed ID: 30169486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery.
    Isla A; Trocóniz IF; de Tejada IL; Vázquez S; Canut A; López JM; Solinís MÁ; Rodríguez Gascón A
    Eur J Clin Pharmacol; 2012 May; 68(5):735-45. PubMed ID: 22246211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and Pharmacodynamic Evaluation of a Weight-Based Dosing Regimen of Cefoxitin for Perioperative Surgical Prophylaxis in Obese and Morbidly Obese Patients.
    Moine P; Mueller SW; Schoen JA; Rothchild KB; Fish DN
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5885-93. PubMed ID: 27458209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of prophylactic cefoxitin in elective bariatric surgery patients: a prospective monocentric study.
    Novy E; Liu X; Hernández-Mitre MP; Belveyre T; Scala-Bertola J; Roberts JA; Parker SL
    Anaesth Crit Care Pain Med; 2024 Jun; 43(3):101376. PubMed ID: 38494157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
    De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin concentrations during cardiopulmonary bypass in pediatric cardiac surgery: a prospective study.
    Ferrari F; Benegni S; Marinari E; Haiberger R; Garisto C; Rizza A; Giorni C; Quattrone MG; Arpicco S; Muntoni E; Milla P; Ricci Z
    Perfusion; 2022 Sep; 37(6):553-561. PubMed ID: 33789546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
    Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
    Gertler R; Gruber M; Wiesner G; Grassin-Delyle S; Urien S; Tassani-Prell P; Martin K
    Br J Clin Pharmacol; 2018 Sep; 84(9):2020-2028. PubMed ID: 29761538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue penetration of cefoxitin in obesity: implications for risk of surgical site infection.
    Toma O; Suntrup P; Stefanescu A; London A; Mutch M; Kharasch E
    Anesth Analg; 2011 Oct; 113(4):730-7. PubMed ID: 21642605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
    Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the Obesity Phenotype on the Adequacy of Antibiotic Prophylaxis with Cefoxitin for Obese Patients Undergoing Bariatric Surgery: Lessons Learnt and Future Considerations.
    Belveyre T; Scala-Bertola J; Esposito M; Luc A; Lipman J; Novy E
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):479-485. PubMed ID: 33959888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessing the dosing of cefoxitin prophylaxis during major abdominal surgery: insights from microdialysis and population pharmacokinetic modelling.
    Boisson M; Torres BGS; Yani S; Couet W; Mimoz O; Dahyot-Fizelier C; Marchand S; Grégoire N
    J Antimicrob Chemother; 2019 Jul; 74(7):1975-1983. PubMed ID: 31220258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.
    Brunetti L; Kagan L; Forrester G; Aleksunes LM; Lin H; Buyske S; Nahass RG
    Clin Ther; 2016 Jan; 38(1):204-10. PubMed ID: 26686826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children.
    Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A
    J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new pharmacokinetic model for target-concentration controlled infusion of cefoxitin as a prophylactic antibiotic in colorectal surgical patients.
    Kim KM; Kim SH; Yun HY; Jung J; Bang JY; Lee EK; Choi BM; Noh GJ
    Br J Clin Pharmacol; 2021 Dec; 87(12):4648-4657. PubMed ID: 33929765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.
    Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR
    Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.